Kathryn R Koller1, Gretchen E Day2, Vanessa Y Hiratsuka3, Julie A Beans3, Sarah H Nash4, Diana G Redwood4, Jianhui Zhu5, Barbara V Howard6, Jason G Umans6. 1. Clinical and Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, United States. Electronic address: kkoller@anthc.org. 2. Clinical and Research Services, Alaska Native Tribal Health Consortium, Anchorage, AK, United States. 3. Research Department, Southcentral Foundation, Anchorage, AK, United States. 4. Alaska Native Epidemiology Center, Alaska Native Tribal Health Consortium, Anchorage, AK, United States. 5. Medstar Health Research Institute, Hyattsville, MD, United States. 6. Medstar Health Research Institute, Hyattsville, MD, United States; Georgetown/Howard Universities, Center for Clinical and Translational Research, Washington, DC, United States.
Abstract
AIMS: This study estimates incidence of diabetes (DM) and pre-DM relative to DM risk factors among relatively healthy Alaska Native and American Indian (henceforth AN) adults living in urban south central Alaska. METHODS: Baseline (2004-2006) and follow-up (2014-2017) surveys, blood samples, and medical chart review data were collected from AN adults living in south central Alaska. We analyzed associations between prevalent risk factors and incident DM and pre-DM using Cox proportional hazards and used multivariable models to identify independent predictors for both DM and pre-DM. RESULTS: Among 379 participants with follow-up data, overall DM incidence was 16.5/1,000 PY; overall pre-DM incidence was 77.6/1,000 PY, with marked differences between men and women. Prevalent cardiometabolic risk factors also varied with greater amounts of overweight in men and greater amounts of obesity in women. Controlling for age and sex, obesity, abdominal adiposity, pre-DM, and metabolic syndrome independently increased DM risk. CONCLUSION: Health care providers of AN populations must seize the opportunity to screen, refer, and treat individuals with pre-DM and other modifiable DM risk factors prior to DM diagnosis if we are to alter the epidemiologic course of disease progression in this urban AN population.
AIMS: This study estimates incidence of diabetes (DM) and pre-DM relative to DM risk factors among relatively healthy Alaska Native and American Indian (henceforth AN) adults living in urban south central Alaska. METHODS: Baseline (2004-2006) and follow-up (2014-2017) surveys, blood samples, and medical chart review data were collected from AN adults living in south central Alaska. We analyzed associations between prevalent risk factors and incident DM and pre-DM using Cox proportional hazards and used multivariable models to identify independent predictors for both DM and pre-DM. RESULTS: Among 379 participants with follow-up data, overall DM incidence was 16.5/1,000 PY; overall pre-DM incidence was 77.6/1,000 PY, with marked differences between men and women. Prevalent cardiometabolic risk factors also varied with greater amounts of overweight in men and greater amounts of obesity in women. Controlling for age and sex, obesity, abdominal adiposity, pre-DM, and metabolic syndrome independently increased DM risk. CONCLUSION: Health care providers of AN populations must seize the opportunity to screen, refer, and treat individuals with pre-DM and other modifiable DM risk factors prior to DM diagnosis if we are to alter the epidemiologic course of disease progression in this urban AN population.
Authors: Sandra L Edwards; Martha L Slattery; Maureen A Murtaugh; Roger L Edwards; James Bryner; Mindy Pearson; Amy Rogers; Alison M Edwards; Lillian Tom-Orme Journal: Am J Epidemiol Date: 2007-03-22 Impact factor: 4.897
Authors: Katherine A Pratte; Ann Johnson; Janette Beals; Ann Bullock; Spero M Manson; Luohua Jiang Journal: Diabetes Care Date: 2019-06-08 Impact factor: 19.112
Authors: Kathryn R Koller; Jesse S Metzger; Stacey E Jolly; Jason G Umans; Scarlett E Hopkins; Cristiane Kaufmann; Amy S Wilson; Sven O E Ebbesson; Terry W Raymer; Melissa A Austin; Barbara V Howard; Bert B Boyer Journal: Diabetes Res Clin Pract Date: 2015-03-11 Impact factor: 5.602
Authors: S E Hopkins; M A Austin; J S Metzger; K R Koller; J G Umans; C Kaufmann; A W Wolfe; B V Howard; B B Boyer Journal: Nutr Metab Cardiovasc Dis Date: 2014-10-29 Impact factor: 4.222
Authors: William C Knowler; Sarah E Fowler; Richard F Hamman; Costas A Christophi; Heather J Hoffman; Anne T Brenneman; Janet O Brown-Friday; Ronald Goldberg; Elizabeth Venditti; David M Nathan Journal: Lancet Date: 2009-10-29 Impact factor: 79.321
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Christi A Patten; Vanessa Y Hiratsuka; Sarah H Nash; Gretchen Day; Diana G Redwood; Julie A Beans; Barbara V Howard; Jason G Umans; Kathryn R Koller Journal: Nicotine Tob Res Date: 2022-04-28 Impact factor: 5.825